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In view of the study limitations, we should avoid 
making a definitive conclusion that resistance training 
is an effective treatment to delay functional decline in 
patients with Charcot-Marie-Tooth disease. However, 
adverse events were few and mild, lending support that 
this type of exercise is not harmful. Understanding of 
the therapeutic response to exercise in neuromuscular 
disease is an important area of study. Simultaneously, 
disease-modifying therapies are now available10 or being 
used in clinical trials, making it difficult to assess the role 
of exercise alone in some neuromuscular populations. 
When possible, exercise therapy should be assessed in 
randomised controlled trials, and adaptive study designs 
or combination therapy might be used when available 
treatment-naive patient populations are scarce or when 
benefits to the concomitant therapy are known, or 
both. The role of adjuvant exercise therapy in enhancing 
benefits of drug therapies should be explored.
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Asthma diagnosis in children: more evidence needed
With about 1–18% of the population worldwide being 
affected, wheeze and asthma are the most prevalent 
chronic respiratory diseases during childhood and 
adulthood.1 As such, many children each day will enter 
an outpatient clinic or a paediatrician’s office needing 
diagnostic tests for suspected asthma. If it were only that 
simple. Individuals with suspected asthma symptoms 
vary substantially in their complaints and clinical 
manifestations despite common pathophysiological 
factors that lead to the final common pathway of 
(sometimes only partly) variable airway obstruction due 
to a range of triggers, which results in symptoms such as 
wheeze, difficulty breathing, chest tightness, and cough.2,3
What is the best way then to diagnose asthma during 
childhood? Importantly, no single test exists for the 
diagnosis of asthma in adults, and especially not in 
children. In diagnostic investigation of patients of all ages, 
clinical observations (ie, suggestive symptoms) need to 
be complemented by objective measurements. These 
tests aim to rule in asthma and to rule out important 
differential diagnoses by identifying variable airway 
obstruction or airway inflammation. In mathematical 
terms, asthma diagnosis depends on the patient’s pretest 
probability of having a diagnosis (suggestive symptoms 
and history) in combination with both sensitivity and 
specificity of further corroborating objective tests such 
as lung function. Beyond the individual symptom level, 
this includes the precision of used tests (ie, both their 
positive and negative predictive values). Therefore, 
asthma diagnosis is a common clinical task that needs to 
be taken seriously, and the importance of such diagnosis 
is reflected by a range of recommendations.1,4,5
The present asthma management guidelines by 
the British Thoracic Society/Scottish Intercollegiate 
Guidelines Network allude to the fact that the diagnosis 
of asthma is primarily a clinical one.4 To prevent 
misdiagnosis, the UK National Institute for Health and 
Care Excellence (NICE) developed additional guidance 
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for asthma diagnosis incorporating objective tests in 
addition to suggestive clinical observations.6 Although 
the NICE guidance is mainly based on data extrapolated 
from adults and yet to be effected in the UK, it proposes 
an algorithm with a predefined sequence of four lung 
function measurements for use in the paediatric context.6 
The algorithm starts with spirometry as a first-line 
measure, followed by a bronchodilator reversibility test, 
measurement of exhaled nitric oxide as a marker of 
allergic airway inflammation, and, if needed, recording of 
peak expiratory flow variability over 2–4 weeks.6 However, 
the dilemma is that although the clinical symptoms 
themselves are already poor predictors for asthma, test 
results can vary over time, as a result of both the variable 
nature of the underlying pathophysiology and the 
resulting asthma symptoms.4 Moreover, lung function 
criteria are limited in their usability, especially during 
childhood if more or less fixed cutoffs irrespective of age 
are used.7 In addition, many difficulties exist with regards 
to peak expiratory flow recordings or the so far absent 
universal definition of bronchodilator reversibility in 
children. These issues have immense implications on the 
combination of the aforementioned pretest probabilities 
for asthma diagnosis and on further objective tests and 
their precision.
The issue of applying guidelines in children that 
originate from studies in adults becomes evident 
in the study by Clare Murray and colleagues8 in 
The Lancet Child & Adolescent Health. The authors 
assessed the usefulness of the newly proposed NICE 
diagnostic algorithm for asthma diagnosis in children 
aged 13–16 years during regular follow-up visits as 
part of a well established population-based birth cohort, 
the Manchester Asthma and Allergy Study (MAAS).9 
To simulate asthma assessment in the primary care 
setting, Murray and colleagues did their analyses in 
a subgroup of study participants with recent asthma 
symptoms who were not already on regular treatment 
with inhaled corticosteroids.8 Unsurprisingly, the authors 
found only poor agreement between the proposed NICE 
algorithm and their definition of asthma in children aged 
13–16 years, which is questionnaire-based and follows 
widely used epidemiological classifications.8 Only two of 
89 symptomatic children met the algorithm’s definition 
of asthma, but neither met the epidemiological 
definition. Although adherence to the NICE algorithm 
under real-life settings resulted in a substantial number 
of false-positives, many children diagnosed with asthma 
by the MAAS criteria would not have been identified if 
the proposed NICE algorithm was followed.8
In view of the scarcity of available population-based 
data on lung function in acutely symptomatic children 
who are not on controller medication, Murray and 
colleagues used the data they had already at hand. As 
they acknowledge in their discussion,8 this subgroup of 
the MAAS birth cohort (ie, adolescents not on regular 
controller treatment) is unlikely to be a valuable proxy 
for children with asthma symptoms in real-life settings. 
In mathematical terms, this issue translates to the 
problem of whether the patients with asthma used for 
the analyses by Murray and colleagues have a similar 
distribution of pretest probability for asthma diagnoses, 
in combination with the precision of further objective 
tests as proposed by the NICE algorithm, to that of 
children with newly presenting asthma symptoms.
Nevertheless, the study by Murray and colleagues8 
is essential and, despite its limitations, the clinical 
message of the Article is an important one: algorithms 
to diagnose disease based on data extrapolated from 
adults should not be used in children and especially 
not without a proper reflection of their limitations. As 
such, until data have been collected in a setting that 
resembles the real-life situation in everyday practice, 
these data are the best we can get for now. Ideally, 
data would be gathered in children with new-onset 
symptoms and therefore at an early stage of disease, 
who did all the diagnostic tests while being acutely 
symptomatic, and were not yet on regular treatment 
with inhaled corticosteroids. However, although we 
may wish for these ideal data and perfect guidelines 
for asthma diagnosis in children, better evidence 
is unlikely to become available, at least not in the 
near future.
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Defining sepsis (with or without positive blood cultures) 
Over the years, a key issue with studies on sepsis has 
been how best to define this condition. Clear consensus 
definitions are now in place to acknowledge that what 
we call sepsis actually represents a bad infection— 
ie, an infection with some organ dysfunction attributed 
to it (panel).1 By contrast with colonisation, infection 
typically includes a host response, usually with fever and 
associated tachycardia, and an altered white-blood-cell 
count (usually an increase, but sometimes a decrease in 
the most severe cases). Infections can be associated with 
positive blood cultures (ie, documented bacteraemia) 
or not (sometimes simply because blood samples for 
culture were not taken).
The ongoing difficulty with terminology was high-
lighted around 25 years ago when a North American 
consensus conference committee2 proposed that sepsis 
be called an infection with some signs of host response 
(the systemic inflammatory response syndrome 
[SIRS] criteria), leading to confusion between the 
words infection and sepsis. This confusion resulted 
in an apparent increase in the incidence of so-called 
sepsis worldwide.3 In the paediatric population, some 
clinicians still apply criteria proposed by Goldstein and 
colleagues4 more than 10 years ago to define sepsis, 
which include the presence of SIRS.
In The Lancet Child & Adolescent Health, Philipp Agyeman 
and colleagues5 report outcomes of 1181 episodes of 
blood culture-proven bacterial infection in children 
(aged <17 years), using data obtained prospectively 
from ten paediatric hospitals in Switzerland over 
4 years. The authors included patients with positive 
blood cultures and suspected infection and SIRS, as per 
the Goldstein definition.4 They used the term “blood 
culture-proven bacterial sepsis” to describe these cases, 
although whether this should be called sepsis remains 
open to debate. The authors noted a low proportion 
of meticillin-resistant staphylococci (eight [1%] of 
1181 episodes) and carbapenemase-resistant organisms 
(five [<1%] of 1181); indeed, Switzerland has a low 
incidence of resistant microorganisms compared with 
other countries in Europe.6,7
Agyeman and colleagues reported organ dysfunction 
in 455 (39%) of 1181 episodes of documented 
bacteraemia, a finding that is hard to interpret but not 
too surprising. Children with organ dysfunction and 
Panel: Current vocabulary for infection and sepsis
Colonisation
Presence of bacteria without host response—eg, gut 
colonisation, tracheal colonisation in intubated patients
Infection
Microbial invasion of sterile or non-sterile organs, usually 
associated with a host response—eg, fever and associated 
tachycardia, altered leucocytosis, increased C-reactive protein 
or procalcitonin
Bacteraemia
Documented presence of microorganisms in the blood 
(ie, positive blood culture)
Sepsis
Organ dysfunction associated with an infection
Septicaemia*
Sepsis with bacteraemia
Septic shock
Sepsis with signs of altered tissue perfusion and lactic acidosis
*Old term and not meaningful so largely abandoned.
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